Katherine Marrs Named CEO of Grenova, Leading the Next Era of Sustainable Laboratory Solutions
Key Highlights Katherine Marrs promoted to CEO, succeeding Lane Major Marrs brings 16 months of strategic growth experience as CCO Grenova…
Koneksa Appoints Eric Luthi as Chief Business Officer
Key Highlights Eric Luthi appointed as Chief Business Officer at Koneksa. 25+ years of experience in life sciences, leading business…
Cardinal Health Acquires Majority Stake in GI Alliance for $3.9B
Key Highlights Cardinal Health to acquire majority stake in GI Alliance (GIA), valuing GIA at $3.9 billion. GIA’s vast network: Over…
GE HealthCare and DeepHealth Partner to Transform AI in Imaging
Key Highlights GE HealthCare and DeepHealth collaboration aims to accelerate AI adoption in imaging. SmartTechnology™ solutions will enhance clinical interpretation,…
Geron Corporation Appoints Dr. Joseph Eid as EVP of R&D to Lead Medical Innovations
Key Highlights Dr. Joseph Eid appointed Executive Vice President, Research and Development, effective November 11, 2024. Over 20 years of…
Conflixis Secures $4.2M Seed Funding to Advance Healthcare Transparency
Key Highlights $4.2M seed funding co-led by Lerer Hippeau, Origin Ventures New investment expands Conflixis’ influence models and analytics Enhanced transparency to…
Health Catalyst Acquires Cybersecurity Leader Intraprise Health
Key Highlights Health Catalyst to acquire Intraprise Health in Q4 2024 to expand cybersecurity and risk management offerings. Intraprise…
Maverick Medical AI Launches Real-Time Medical Coding Solution
Key Highlights Maverick CodePilot™: Real-time medical coding solution enhancing the mid-revenue cycle. 85% Direct-to-Bill Rates: Achieved on go-live, boosting coding…
Veravas and Phanes Biotech Partner to Develop Blood-Based Alzheimer’s Diagnostic Test
Key Highlights Veravas partners with Phanes Biotech to co-develop a blood-based Alzheimer’s diagnostic. New test uses VeraBIND™ technology to detect…
Tempus AI Launches Immune Profile Score to Enhance Cancer Treatment
Key Highlights Tempus AI launches Immune Profile Score (IPS) for clinicians to advance cancer care. Prognostic tool for stage…